FDA Approves New Botox Rival

🚨 New Toxin Lasts Longer
🚨 Approved label includes full 36-week efficacy data from Phase 3 SAKURA clinical program, positioning DAXXIFY™ as the first and only long-acting neuromodulator that demonstrates a median duration of six months and up to nine months for some patients1- 6* ‡
Based on the data from SAKURA, DAXXIFY™ has the ability to deliver year-long results with as few as two treatments per year and has been proven to be effective, generally safe and well tolerated2-5 *
DAXXIFY™, powered by Peptide Exchange Technology™, is the first true innovation in neuromodulator product formulation in over 30 years
Is longer better? In most cases I would say YES. Please keep in mind that if you get an unwanted affect from your tocsin it would last even longer. Another reason for you always seeing an experienced expert if you were thinking of getting this product
Source WSJ